In this context, the pivotal role of FLG-AS1 in inhibiting glucose uptake and lactic acid production in ESCC cells has been elucidated, acting through the modulation of the miR-23a-3p/HOXD10 axis. Here, HOXD10 is linked to esophageal squamous cell carcinoma.